miR-21

Fibrosis therapeutic treatment in a muscular dystrophy context
A palliative treatment for fibrosis in a Muscular Dystrophy context consisting in an antago-miRNA that effectively enhances tissue regeneration and ameliorates fibrosis. Allows for a slower...
Subscribe to miR-21